Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Discontinued OperationsCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionDivestmentsExchange Rate EffectFree Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

AC Immune (ACIU) Cash from Investing Activities (2016 - 2025)

Historic Cash from Investing Activities for AC Immune (ACIU) over the last 11 years, with Q3 2025 value amounting to $25.8 million.

  • AC Immune's Cash from Investing Activities rose 117050.0% to $25.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $53.6 million, marking a year-over-year increase of 16165.35%. This contributed to the annual value of -$120.2 million for FY2024, which is 26240.87% down from last year.
  • AC Immune's Cash from Investing Activities amounted to $25.8 million in Q3 2025, which was up 117050.0% from $28.8 million recorded in Q2 2025.
  • In the past 5 years, AC Immune's Cash from Investing Activities registered a high of $46.3 million during Q1 2023, and its lowest value of -$83.8 million during Q2 2024.
  • Its 5-year average for Cash from Investing Activities is -$1.1 million, with a median of -$584716.6 in 2022.
  • As far as peak fluctuations go, AC Immune's Cash from Investing Activities soared by 801387.77% in 2023, and later crashed by 136228.8% in 2024.
  • Over the past 5 years, AC Immune's Cash from Investing Activities (Quarter) stood at -$23.6 million in 2021, then skyrocketed by 121.85% to $5.1 million in 2022, then surged by 409.85% to $26.2 million in 2023, then crashed by 116.64% to -$4.4 million in 2024, then surged by 690.42% to $25.8 million in 2025.
  • Its last three reported values are $25.8 million in Q3 2025, $28.8 million for Q2 2025, and $3.4 million during Q1 2025.